208 related articles for article (PubMed ID: 24421047)
1. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
Melillo AA; Foreman O; Bosio CM; Elkins KL
Infect Immun; 2014 Apr; 82(4):1477-90. PubMed ID: 24421047
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL
Infect Immun; 2013 Feb; 81(2):585-97. PubMed ID: 23230288
[TBL] [Abstract][Full Text] [Related]
3. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
4. T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.
Collazo CM; Meierovics AI; De Pascalis R; Wu TH; Lyons CR; Elkins KL
Infect Immun; 2009 May; 77(5):2010-21. PubMed ID: 19237526
[TBL] [Abstract][Full Text] [Related]
5. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
6. An
Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
[No Abstract] [Full Text] [Related]
7. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
8. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
[TBL] [Abstract][Full Text] [Related]
9. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
Elkins KL; Colombini SM; Meierovics AI; Chu MC; Chou AY; Cowley SC
Microbes Infect; 2010 Jan; 12(1):28-36. PubMed ID: 19781659
[TBL] [Abstract][Full Text] [Related]
10. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
11. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.
Elkins KL; Cooper A; Colombini SM; Cowley SC; Kieffer TL
Infect Immun; 2002 Apr; 70(4):1936-48. PubMed ID: 11895957
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
Roberts LM; Davies JS; Sempowski GD; Frelinger JA
Vaccine; 2014 Jun; 32(29):3595-603. PubMed ID: 24837506
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
[TBL] [Abstract][Full Text] [Related]
14. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
15. Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.
Franz BJ; Li Y; Bitsaktsis C; Iglesias BV; Pham G; Sunagar R; Kumar S; Gosselin EJ
J Immunol Res; 2015; 2015():840842. PubMed ID: 25961064
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
17. Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.
Cowley SC; Sedgwick JD; Elkins KL
J Immunol; 2007 Dec; 179(11):7709-19. PubMed ID: 18025217
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.
Woolard MD; Hensley LL; Kawula TH; Frelinger JA
Infect Immun; 2008 Jun; 76(6):2651-9. PubMed ID: 18391003
[TBL] [Abstract][Full Text] [Related]
19. IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection.
Melillo AA; Foreman O; Elkins KL
J Leukoc Biol; 2013 May; 93(5):657-67. PubMed ID: 23440500
[TBL] [Abstract][Full Text] [Related]
20. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.
Anderson RV; Crane DD; Bosio CM
Vaccine; 2010 Sep; 28(40):6562-72. PubMed ID: 20688042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
